Rexahn Pharmaceuticals Announces Preliminary Safety And Efficacy Data From Ongoing Phase 2a Clinical Trial Of RX-3117 in Combination With Abraxane In Patients Newly Diagnosed With Metastatic Pancreatic Cancer